Загрузка...

Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

Inhibitors of the mammalian target of rapamycin (mTOR) have improved the treatment of renal cell carcinoma (RCC). However, chronic drug exposure may trigger resistance, limiting the utility of these agents. The metastatic behavior of RCC cells, susceptible (RCCpar) or resistant (RCCres) to the mTOR...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2014-04-01
Серии:Neoplasia: An International Journal for Oncology Research
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S147655861400030X
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!